Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Object Symbol | Species | Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | ANXA13 | Human | (+)-catechin | multiple interactions | EXP | | 6480464 | [Catechin co-treated with Grape Seed Proanthocyanidins] results in decreased expression of ANXA13 mRNA | CTD | PMID:24763279 | ANXA13 | Human | (1->4)-beta-D-glucan | multiple interactions | ISO | Anxa13 (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of ANXA13 mRNA | CTD | PMID:36331819 | ANXA13 | Human | 1,2-dichloroethane | increases expression | ISO | Anxa13 (Mus musculus) | 6480464 | ethylene dichloride results in increased expression of ANXA13 mRNA | CTD | PMID:28960355 | ANXA13 | Human | 1,2-dimethylhydrazine | decreases expression | ISO | Anxa13 (Mus musculus) | 6480464 | 1 and 2-Dimethylhydrazine results in decreased expression of ANXA13 mRNA | CTD | PMID:22206623 | ANXA13 | Human | 1-naphthyl isothiocyanate | increases expression | ISO | Anxa13 (Rattus norvegicus) | 6480464 | 1-Naphthylisothiocyanate results in increased expression of ANXA13 mRNA | CTD | PMID:30723492 | ANXA13 | Human | 17alpha-ethynylestradiol | multiple interactions | ISO | Anxa13 (Mus musculus) | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of ANXA13 mRNA | CTD | PMID:17942748 | ANXA13 | Human | 17beta-estradiol | multiple interactions | ISO | Anxa13 (Rattus norvegicus) | 6480464 | [bisphenol A co-treated with Estradiol] results in increased expression of ANXA13 mRNA and [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of ANXA13 mRNA | CTD | PMID:26496021 and PMID:32741896 | ANXA13 | Human | 17beta-estradiol | increases expression | ISO | Anxa13 (Rattus norvegicus) | 6480464 | Estradiol results in increased expression of ANXA13 mRNA | CTD | PMID:32145629 | ANXA13 | Human | 17beta-estradiol 3-benzoate | multiple interactions | ISO | Anxa13 (Rattus norvegicus) | 6480464 | [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of ANXA13 mRNA | CTD | PMID:32741896 | ANXA13 | Human | 2,3,4,7,8-Pentachlorodibenzofuran | decreases expression | ISO | Anxa13 (Rattus norvegicus) | 6480464 | 2 more ... | CTD | PMID:21724226 | ANXA13 | Human | 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | Anxa13 (Mus musculus) | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of ANXA13 mRNA | CTD | PMID:17942748 | ANXA13 | Human | 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | EXP | | 6480464 | [Endosulfan co-treated with Tetrachlorodibenzodioxin] results in decreased expression of ANXA13 mRNA | CTD | PMID:26159488 | ANXA13 | Human | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | Anxa13 (Rattus norvegicus) | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of ANXA13 mRNA | CTD | PMID:21724226 | ANXA13 | Human | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | Anxa13 (Rattus norvegicus) | 6480464 | Tetrachlorodibenzodioxin affects the expression of ANXA13 mRNA | CTD | PMID:22298810 | ANXA13 | Human | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | EXP | | 6480464 | Tetrachlorodibenzodioxin affects the expression of ANXA13 mRNA | CTD | PMID:22298810 | ANXA13 | Human | 2,3,7,8-Tetrachlorodibenzofuran | decreases expression | ISO | Anxa13 (Rattus norvegicus) | 6480464 | 2 more ... | CTD | PMID:21724226 | ANXA13 | Human | 2,4-dinitrotoluene | affects expression | ISO | Anxa13 (Rattus norvegicus) | 6480464 | 2 and 4-dinitrotoluene affects the expression of ANXA13 mRNA | CTD | PMID:21346803 | ANXA13 | Human | 2,6-dinitrotoluene | affects expression | ISO | Anxa13 (Rattus norvegicus) | 6480464 | 2 and 6-dinitrotoluene affects the expression of ANXA13 mRNA | CTD | PMID:21346803 | ANXA13 | Human | acetamide | increases expression | ISO | Anxa13 (Rattus norvegicus) | 6480464 | acetamide results in increased expression of ANXA13 mRNA | CTD | PMID:31881176 | ANXA13 | Human | aflatoxin B1 | increases expression | ISO | Anxa13 (Rattus norvegicus) | 6480464 | Aflatoxin B1 results in increased expression of ANXA13 mRNA | CTD | PMID:23630614 more ... | ANXA13 | Human | aflatoxin B1 | decreases methylation | EXP | | 6480464 | Aflatoxin B1 results in decreased methylation of ANXA13 gene | CTD | PMID:27153756 | ANXA13 | Human | aristolochic acid A | multiple interactions | ISO | Anxa13 (Rattus norvegicus) | 6480464 | [aristolochic acid I co-treated with aristolochic acid II] results in decreased expression of ANXA13 mRNA | CTD | PMID:23912714 | ANXA13 | Human | Benzo[ghi]perylene | increases expression | ISO | Anxa13 (Mus musculus) | 6480464 | 1 and 12-benzoperylene results in increased expression of ANXA13 mRNA | CTD | PMID:26377693 | ANXA13 | Human | bisphenol A | multiple interactions | ISO | Anxa13 (Rattus norvegicus) | 6480464 | [bisphenol A co-treated with Estradiol] results in increased expression of ANXA13 mRNA | CTD | PMID:26496021 | ANXA13 | Human | bisphenol A | increases expression | ISO | Anxa13 (Rattus norvegicus) | 6480464 | bisphenol A results in increased expression of ANXA13 mRNA | CTD | PMID:32145629 | ANXA13 | Human | bisphenol A | decreases expression | ISO | Anxa13 (Rattus norvegicus) | 6480464 | bisphenol A results in decreased expression of ANXA13 mRNA | CTD | PMID:25181051 | ANXA13 | Human | bromobenzene | increases expression | ISO | Anxa13 (Rattus norvegicus) | 6480464 | bromobenzene results in increased expression of ANXA13 mRNA | CTD | PMID:32479839 | ANXA13 | Human | butanal | decreases expression | EXP | | 6480464 | butyraldehyde results in decreased expression of ANXA13 mRNA | CTD | PMID:26079696 | ANXA13 | Human | cefaloridine | decreases expression | ISO | Anxa13 (Rattus norvegicus) | 6480464 | Cephaloridine results in decreased expression of ANXA13 mRNA | CTD | PMID:18500788 | ANXA13 | Human | CGP 52608 | multiple interactions | EXP | | 6480464 | CGP 52608 promotes the reaction [RORA protein binds to ANXA13 gene] | CTD | PMID:28238834 | ANXA13 | Human | choline | multiple interactions | ISO | Anxa13 (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of ANXA13 mRNA | CTD | PMID:20938992 | ANXA13 | Human | cisplatin | multiple interactions | EXP | | 6480464 | [Cisplatin co-treated with jinfukang] results in increased expression of ANXA13 mRNA | CTD | PMID:27392435 | ANXA13 | Human | cyclosporin A | decreases expression | EXP | | 6480464 | Cyclosporine results in decreased expression of ANXA13 mRNA | CTD | PMID:27989131 | ANXA13 | Human | DDT | decreases methylation | ISO | Anxa13 (Rattus norvegicus) | 6480464 | DDT results in decreased methylation of ANXA13 gene | CTD | PMID:31682807 | ANXA13 | Human | endosulfan | multiple interactions | EXP | | 6480464 | [Endosulfan co-treated with Tetrachlorodibenzodioxin] results in decreased expression of ANXA13 mRNA | CTD | PMID:26159488 | ANXA13 | Human | endosulfan | decreases expression | ISO | Anxa13 (Rattus norvegicus) | 6480464 | Endosulfan results in decreased expression of ANXA13 mRNA | CTD | PMID:29391264 | ANXA13 | Human | folic acid | affects expression | EXP | | 6480464 | Folic Acid affects the expression of ANXA13 mRNA | CTD | PMID:17868486 | ANXA13 | Human | folic acid | multiple interactions | ISO | Anxa13 (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of ANXA13 mRNA | CTD | PMID:20938992 | ANXA13 | Human | furan | increases expression | ISO | Anxa13 (Rattus norvegicus) | 6480464 | furan results in increased expression of ANXA13 mRNA | CTD | PMID:27387713 | ANXA13 | Human | hydrogen peroxide | affects expression | EXP | | 6480464 | Hydrogen Peroxide affects the expression of ANXA13 mRNA | CTD | PMID:20044591 | ANXA13 | Human | inulin | multiple interactions | ISO | Anxa13 (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of ANXA13 mRNA | CTD | PMID:36331819 | ANXA13 | Human | irinotecan | decreases expression | EXP | | 6480464 | Irinotecan analog results in decreased expression of ANXA13 mRNA | CTD | PMID:18927307 | ANXA13 | Human | L-methionine | multiple interactions | ISO | Anxa13 (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of ANXA13 mRNA | CTD | PMID:20938992 | ANXA13 | Human | menadione | affects expression | EXP | | 6480464 | Vitamin K 3 affects the expression of ANXA13 mRNA | CTD | PMID:20044591 | ANXA13 | Human | N,N-diethyl-m-toluamide | multiple interactions | ISO | Anxa13 (Rattus norvegicus) | 6480464 | [Permethrin co-treated with DEET] results in decreased methylation of ANXA13 gene | CTD | PMID:33148267 | ANXA13 | Human | ochratoxin A | decreases expression | ISO | Anxa13 (Rattus norvegicus) | 6480464 | ochratoxin A results in decreased expression of ANXA13 mRNA | CTD | PMID:30449730 | ANXA13 | Human | paracetamol | decreases expression | EXP | | 6480464 | Acetaminophen results in decreased expression of ANXA13 mRNA | CTD | PMID:26690555 and PMID:29067470 | ANXA13 | Human | pentanal | decreases expression | EXP | | 6480464 | pentanal results in decreased expression of ANXA13 mRNA | CTD | PMID:26079696 | ANXA13 | Human | perfluorohexanesulfonic acid | increases expression | ISO | Anxa13 (Mus musculus) | 6480464 | perfluorohexanesulfonic acid results in increased expression of ANXA13 mRNA | CTD | PMID:37995155 | ANXA13 | Human | perfluorononanoic acid | decreases expression | EXP | | 6480464 | perfluoro-n-nonanoic acid results in decreased expression of ANXA13 mRNA | CTD | PMID:32588087 | ANXA13 | Human | perfluorooctane-1-sulfonic acid | multiple interactions | ISO | Anxa13 (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of ANXA13 mRNA more ... | CTD | PMID:36331819 | ANXA13 | Human | perfluorooctanoic acid | decreases expression | ISO | Anxa13 (Rattus norvegicus) | 6480464 | perfluorooctanoic acid results in decreased expression of ANXA13 mRNA | CTD | PMID:28511854 | ANXA13 | Human | permethrin | multiple interactions | ISO | Anxa13 (Rattus norvegicus) | 6480464 | [Permethrin co-treated with DEET] results in decreased methylation of ANXA13 gene | CTD | PMID:33148267 | ANXA13 | Human | pirinixic acid | multiple interactions | EXP | | 6480464 | [pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of ANXA13 mRNA | CTD | PMID:19710929 | ANXA13 | Human | pirinixic acid | increases expression | ISO | Anxa13 (Mus musculus) | 6480464 | pirinixic acid results in increased expression of ANXA13 mRNA | CTD | PMID:17426115 more ... | ANXA13 | Human | propanal | decreases expression | EXP | | 6480464 | propionaldehyde results in decreased expression of ANXA13 mRNA | CTD | PMID:26079696 | ANXA13 | Human | silicon dioxide | decreases expression | EXP | | 6480464 | Silicon Dioxide analog results in decreased expression of ANXA13 mRNA | CTD | PMID:25895662 | ANXA13 | Human | sodium arsenite | affects methylation | EXP | | 6480464 | sodium arsenite affects the methylation of ANXA13 gene | CTD | PMID:28589171 | ANXA13 | Human | testosterone | multiple interactions | ISO | Anxa13 (Rattus norvegicus) | 6480464 | [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of ANXA13 mRNA | CTD | PMID:32741896 | ANXA13 | Human | tetrachloroethene | decreases expression | ISO | Anxa13 (Mus musculus) | 6480464 | Tetrachloroethylene results in decreased expression of ANXA13 mRNA | CTD | PMID:28973375 | ANXA13 | Human | thioacetamide | increases expression | ISO | Anxa13 (Rattus norvegicus) | 6480464 | Thioacetamide results in increased expression of ANXA13 mRNA | CTD | PMID:23411599 | ANXA13 | Human | titanium dioxide | decreases expression | ISO | Anxa13 (Mus musculus) | 6480464 | titanium dioxide results in decreased expression of ANXA13 mRNA | CTD | PMID:23557971 | ANXA13 | Human | titanium dioxide | decreases expression | EXP | | 6480464 | titanium dioxide results in decreased expression of ANXA13 mRNA | CTD | PMID:34973136 | ANXA13 | Human | Triptolide | increases expression | ISO | Anxa13 (Rattus norvegicus) | 6480464 | triptolide results in increased expression of ANXA13 protein | CTD | PMID:32519852 | ANXA13 | Human | valproic acid | decreases expression | EXP | | 6480464 | Valproic Acid results in decreased expression of ANXA13 mRNA | CTD | PMID:29154799 | ANXA13 | Human | vinclozolin | increases methylation | ISO | Anxa13 (Rattus norvegicus) | 6480464 | vinclozolin results in increased methylation of ANXA13 gene | CTD | PMID:31079544 | |